(MENAFN- GlobeNewsWire - Nasdaq) Globally, NIPT is seeing increasing uptake across hospitals and diagnostic laboratories as demand for safer, early fetal screening rise and prenatal care pathways ...

When discussing the value of screening for 22q, the authors concluded that, “the PPV of cfDNA for 22q11.2DS is higher and the false positive rate is lower than that associated with other accepted ...

The global Prenatal Genetic Testing Market is valued at USD 7.01 billion in 2024 and is projected to reach a value of USD 24.125 billion by 2035 at a CAGR (Compound Annual Growth Rate) of 11.95% ...

Dublin, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The "Prenatal and Newborn Genetic Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive ...

The Global Non-Invasive Prenatal Testing (NIPT) Market is expected to grow at 16% by 2029. The high risk of chromosomal abnormalities with rising maternal age, the surge in the adoption of cell-free ...

Myriad Genetics, Inc. announced it will present significant research on early prenatal testing at the Society for Maternal-Fetal Medicine Conference. The study, awarded the Dru Carlson Memorial Award, ...

The adoption of NIPT has drastically reduced the need for risky invasive procedures like amniocentesis. In places like Switzerland, public health coverage of NIPT led to a 50% drop in amniocenteses.

Early identification of potential issues also allows healthcare providers to tailor prenatal care to meet the specific needs of the pregnancy and baby. This may include specialized monitoring, ...

Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "United States Non-Invasive Prenatal Testing (NIPT) Market Report 2025: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, ...

Lucknow: Prenatal screening is not just about early detection but about informed choices for well-being of mother and child. This was highlighted at a continuing medical education programme organised ...